Sources: Foxconn workers in Zhengzhou say they got COVID-19 in December 2022 and some were asked to keep working; one supervisor advised workers against testing
Context & Ripple Effects
Foxconn's Zhengzhou complex has spent the past two months lurching between containment regimes: a weekslong October outbreak met with harsh lockdown measures inside the iPhone plant, then a November of worker unrest and an 11.4% year-over-year revenue drop, followed by a December pivot as China rolled back its national COVID-19 rules and Foxconn began easing most restrictions on workers' daily movements.
The new reporting cuts against the recovery narrative. Even as the city lifted its lockdown and Foxconn moved to resume full production, workers say infections continued into December, that some were asked to keep working while ill, and that a supervisor advised against testing — a direct tension with the closed-loop system Foxconn had kept in place to control movement between dorms and the factory floor.
First-order effects
- Workers on the Zhengzhou line face the immediate consequence: illness no longer triggers isolation or testing under the relaxed regime, and some say they were expected to work through infection during the final push toward full production.
- Foxconn's stated timeline for resuming full output in late December or early January now rests on a workforce it was, per workers' accounts, discouraging from confirming infections.
Second-order effects
- Apple's peak-season iPhone supply runs through this single campus, and the same plant that drove November's 11.4% revenue decline is now the bottleneck for the ramp — continued on-floor transmission is a direct production-risk variable.
- With China abandoning mass testing and lockdowns, containment responsibility shifts to employers, making Foxconn's dorm-and-floor closed-loop the de facto control point — and its supervisors the de facto health authorities.
Third-order effects
- If the pattern holds, China's exit from zero-COVID converts factory health management into a self-policing employer practice, raising labor-scrutiny and brand risk for Apple and its suppliers precisely as the state's oversight recedes.
- The Zhengzhou experience becomes the template case for how export-manufacturing hubs absorb a nationwide infection wave: production continuity prioritized, testing optional, and the costs of illness absorbed by the workforce.
The trend: China's rollback of zero-COVID is shifting infection control from state enforcement to individual employers, with Foxconn's Zhengzhou plant the most consequential test case.